Pfizer, others seek untapped potential in virtual clinical trials

Drugmakers have widely acknowledged that they need to streamline their R&D processes, and many have embarked on the use of digital technologies to improve the efficiency of the clinical development process. In an article in Life Science Leader, Pfizer's Craig Lipset talked about how the company's virtual clinical trial rolled out many new tech tools at once to trial the overall bladder drug Detrol, with some setbacks along the way. But the drug giant ($PFE) will resume the virtual program next year. Article

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.